Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 9, 2026

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.8K

Advances in islet encapsulation technologies.

Tejal Desai1, Lonnie D Shea2

  • 1University of California, San Francisco, Department of Bioengineering and Therapeutic Sciences, Byers Hall Rm 203C, MC 2520, 1700 4th Street, San Francisco, California 94158-2330, USA.

Nature Reviews. Drug Discovery
|December 24, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory B cells contribute to allergen-encapsulating nanoparticle immunotherapy efficacy for food allergy.

JCI insight·2026
Same author

Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.

bioRxiv : the preprint server for biology·2026
Same author

Nanoparticle modulation of immune and vascular microenvironment dynamics following spinal cord injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Nanoparticle induction of antigen-presenting monocyte-derived dendritic cells relieves immunosuppression and inhibits metastasis.

Cell biomaterials·2026
Same author

Synthetic Immunological Niche Reveals Early Immune Dysregulation and Stratifies Therapeutic Response in Type 1 Diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Longitudinal monitoring of type 1 diabetes progression to disease onset.

Science advances·2026
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Encapsulating islet cells could overcome type 1 diabetes treatment barriers like donor shortage and immune rejection. This innovative approach holds promise for future human therapies, potentially eliminating the need for lifelong immunosuppression.

Area of Science:

  • Immunology
  • Endocrinology
  • Biomaterials Science

Background:

  • Type 1 diabetes is an autoimmune disease targeting pancreatic islet cells.
  • Islet transplantation is effective but limited by donor scarcity and immunosuppression needs.

Purpose of the Study:

  • To explore encapsulation as a strategy to overcome barriers in islet transplantation.
  • To enable the use of xenogeneic or allogeneic stem cell-derived islets.

Main Methods:

  • Investigating encapsulation techniques for pancreatic islet cells.
  • Leveraging advancements in materials science, nanotechnology, and stem cell biology.

Main Results:

  • Encapsulation shows potential to prevent immune rejection of transplanted islets.

More Related Videos

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel
10:20

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel

Published on: June 29, 2017

20.7K
Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

9.9K

Related Experiment Videos

Last Updated: Mar 9, 2026

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.8K
Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel
10:20

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel

Published on: June 29, 2017

20.7K
Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

9.9K
  • This strategy may eliminate the need for lifelong immunosuppression in type 1 diabetes patients.

    • Conclusions:

    • Encapsulated islet cell therapy is a promising avenue for type 1 diabetes treatment.
    • Interdisciplinary collaboration is advancing the feasibility of this therapy for human application.